CSPC Pharmaceutical Group (CSPCY) Stock Price, News & Analysis

Company Overview

CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures and distributes finished pharmaceutical products and active pharmaceutical ingredients, serving hospitals, pharmacies and other healthcare channels.

Its product portfolio includes medicines for neurological, cardiovascular, oncology, anti-infective and other therapeutic areas. CSPC is known for products such as butylphthalide, used in the treatment of ischemic stroke, as well as oncology medicines, injectable therapies and a range of generic drugs. The group also produces bulk pharmaceutical ingredients, including vitamins and antibiotics, along with selected nutraceutical products.

CSPC traces its roots to Shijiazhuang Pharmaceutical Group and has expanded from a traditional manufacturer of bulk drugs and generic medicines into a research-oriented pharmaceutical group. Its operations are primarily based in China, while its products and pharmaceutical ingredients are also supplied to international markets through exports and overseas commercial partnerships.

Key Stats

• Today's Range: C$3.94 to C$3.96
• 50-Day Range: C$3.94 to C$5.21
• 52-Week Range: C$3.26 to C$5.46
• Volume: 3,849 shs
• Average Volume: 2,966 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CSPCY
• CIK: N/A
• Web: www.cspc.com.hk
• Phone: 86-31-1870-37015
• Fax: N/A
• Employees: 19,700
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A